NeuronScore
Signal quality across funding, news, traction & verificationAbout MiRus
MiRus develops and commercialises proprietary biomaterials, implants, and procedural solutions for cardiovascular and orthopedic diseases. Leveraging its unique MoRe® alloy, the company aims to create smaller, stronger, and more biocompatible medical devices. Their integrated platform covers pre-operative, intra-operative, and post-operative care, including advanced remote monitoring.
Funding History
1 round · $1.5B total| Date | Stage | Lead Investors | Amount |
|---|---|---|---|
| May 2026 | Other | Boston Scientific | $1.5B |
OpenEvidence
64AI medical assistant for clinicians
Imperagen
55Closed-loop, AI-guided enzyme engineering for improved and production-ready enzyme designs.
Profluent
50Frontier AI models for programmable biology and protein design
Ambience Healthcare
47The AI operating system for healthcare
Suki AI
44AI voice assistant for clinicians
Recursion
38Pioneering AI-driven solutions in drug discovery to radically improve lives.
FAQ
How much funding has MiRus raised?
MiRus has raised $1.5B across 1 round — most recently a Other led by Boston Scientific in May 2026.
How much does MiRus cost?
MiRus pricing: Enterprise · Contact sales.
Where is MiRus headquartered?
MiRus is headquartered in Marlborough, United States.
Discussion
Sign in to join the discussion.
Sign inExplore more around MiRus
Contextual paths to related AI startups, deals and rankings.